Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions (Tables)

v3.19.1
Composition of Certain Financial Statement Captions (Tables)
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Composition of Certain Financial Statement Captions
(In thousands)
March 31,
2019
 
December 31,
2018
Accounts receivable, net:
 
 
 
Accounts receivable
$
146,333

 
$
145,665

Less: allowance for doubtful accounts
(1,950
)
 
(1,758
)
 
$
144,383

 
$
143,907

Inventories, net:
 
 
 
Consumable supplies
$
21,599

 
$
23,264

Finished products
18,891

 
15,259

Work in-process
2,851

 
2,473

Raw materials
4,729

 
4,259

Less: inventory reserve
(3,460
)
 
(2,956
)
 
$
44,610

 
$
42,299

Other current assets and prepaid expenses:
 
 
 
Taxes recoverable
19,893

 
15,708

Other receivables
(457
)
 
2,368

Prepaid supplies
12,200

 
9,693

Prepaid insurance
2,847

 
3,436

Other
4,511

 
3,847

 
$
38,994

 
$
35,052

Intangible assets, net:
 
 
 
Customer relationships
$
445,661

 
$
446,296

Technologies
340,648

 
340,729

Trade names
50,413

 
50,404

Licenses
5,766

 
5,766

Covenants not to compete
16,318

 
16,322

Product registrations
7,954

 
7,861

Other
5,533

 
5,613

Less: accumulated amortization
(274,977
)
 
(258,539
)
 
$
597,316

 
$
614,452

Accrued expenses:
 
 
 
Contract liabilities
$
65,288

 
$
63,503

Employee benefits
42,354

 
45,621

Clinical trials
11,996

 
10,401

Contingent consideration
2,375

 
2,375

Finance leases short-term
3,077

 
3,280

Milestone payment
4,919

 
4,871

Professional fees
6,689

 
7,935

Other
80,836

 
65,527

 
$
217,534

 
$
203,513

 
 
 
 

(In thousands)
March 31,
2019
 
December 31,
2018
Other long-term liabilities:
 
 
 
Contract liabilities
$
7,708

 
$
27,566

Line of credit

 
105,198

Contingent consideration
26,968

 
22,162

Mortgages and other debts payable
4,322

 
4,654

Finance leases long-term
4,981

 
5,620

Other
34,186

 
33,768

 
$
78,165

 
$
198,968

Changes in Goodwill The following table summarizes the changes in Goodwill during the three months ended March 31, 2019.
 
2019
(In thousands)
Balance at January 1
 
Foreign exchange and other
 
Balance at March 31st
Pharmaceuticals
 
 
 
 
 
CURNA
$
4,827

 
$

 
$
4,827

EirGen
85,245

 
(1,683
)
 
83,562

FineTech

 

 

OPKO Chile
4,614

 
91

 
4,705

OPKO Biologics
139,784

 

 
139,784

OPKO Health Europe
7,545

 
(149
)
 
7,396

OPKO Renal
2,069

 

 
2,069

Transition Therapeutics
3,323

 
70

 
3,393

 
 
 
 
 
 
Diagnostics
 
 
 
 
 
BioReference
401,821

 

 
401,821

OPKO Diagnostics
17,977

 

 
17,977

OPKO Lab
32,988

 

 
32,988

 
$
700,193

 
$
(1,671
)
 
$
698,522